Feature | March 11, 2010

Hybrid Cath Lab Exhibit at ACC Highlights Growing Trend

March 12, 2010 – In partnership with the American College of Cardiology (ACC), Philips is spotlighting the growing need for hybrid cath labs with a specialty exhibit during ACC 2010 March 14-16 in Atlanta. The need to reduce invasive surgical interventions and complication rates is driving innovations in minimally invasive approaches. Philips and ACC will jointly showcase the Hybrid OR Suite on the expo floor, a solution that combines in one room the equipment needed to perform both open and endovascular cardiac procedures. Built out of combined efforts by Philips and its network of alliances, the Hybrid OR Suite will help advance how clinicians attend to patients in cardiac procedures. Traditionally, X-ray imaging is used to navigate cardiac interventions performed in a cardiac catheterization lab. In recent times, importance has grown for 3D ultrasound imaging in visualizing complex structures during interventions. A hybrid OR suite combines the sterility and instruments of a traditional operating room with the X-ray and ultrasound imaging systems and radiation shields of a cath lab. “Using live 3D TEE ultrasound, we can view the anatomy without incisions or surgery,” said Roberto Lang, M.D., director of noninvasive cardiac imaging labs at the University of Chicago Medical Center. “It provides 3D images unlike those from other technology, to help clinicians place therapeutic devices." The cutting-edge hybrid OR configuration not only provides hospitals with a room that is flexible enough to handle a wide variety of treatments and procedures, but it also helps clinicians from a variety of specialties to collaborate. "Multidisciplinary care is gaining broader acceptance as hospitals and healthcare institutions combine approaches and evolve in their delivery of cardiac care,” said Henry Solomon, M.D., chief medical officer for business development at the American College of Cardiology. “Rooms equipped to support both open surgical and minimally invasive endovascular approaches, such as the hybrid OR, are designed to meet the specific needs of clinicians when they are called upon to perform difficult procedures.” The hybrid OR suite on display at this year’s ACC enables clinicians to perform a full range of endovascular, percutaneous and open procedures. Percutaneous procedures enable physicians to utilize minimally invasive catheter-based interventions to treat patients that may be too sick or frail for open interventions, such as in valve replacement surgery. “The patient is happy, the procedure is less invasive and the collaboration between the cardiologist, the cardiac surgeons and industry—with Philips providing the technology—has made that possible,” said Valluvan Jeevanandam, M.D., chief of cardiac and thoracic surgery at the University of Chicago Medical Center. Philips’ hybrid OR suites are customized for customer needs and designed using an advanced 3D architectural planning tool that provides prospective customers with a visual rendering of possible room configurations. From high-quality, high-resolution, multimodality imaging with advanced 3D software to support confident decision-making, to surgical tables, lighting and other equipment considerations, the full scope of equipment combinations is assessed. The Philips Healthcare booth is 1343, and the Hybrid OR Suite is located in booth 2744. Online visitors can visit http://www.philips.com/media or www.philips.com/hybridor

Related Content

Bilateral Artery Use Does Not Improve 10-Year CABG Outcomes
News | Cardiovascular Surgery | September 06, 2018
While it is firmly established that the use of one internal thoracic artery can improve life expectancy in coronary...
Mandatory Public Coronary Artery Bypass Grafting Reporting Associated With Better Patient Outcomes
News | Cardiovascular Surgery | April 30, 2018
Mandatory public reporting of coronary artery bypass grafting (CABG) results in Massachusetts was associated with...
Gecko Biomedical Receives CE Mark Approval for Setalum Sealant
News | Cardiovascular Surgery | September 19, 2017
Gecko Biomedical announced it has received CE Mark approval for its Setalum Sealant, allowing the company to market its...
ClearFlow Inc. Announces Positive U.S. Clinical Trial Results
News | Cardiovascular Surgery | September 08, 2017
September 8, 2017 — ClearFlow Inc.
Videos | Cardiovascular Surgery | July 19, 2017
This video educational session, provided in partnership with the American Society of Echocardiography (ASE), is title
Intensive Glycemic Control Program Produces Significant Per-Patient Cost Savings for CABG Surgery
News | Cardiovascular Surgery | May 25, 2017
A new study from Emory University observed a near-20 percent reduction in perioperative complications, a 1.2-day...
Risk of Heart Transplant Rejection Reduced by Desensitizing Patient Antibodies
News | Cardiovascular Surgery | May 23, 2017
The risk of heart transplant rejection can be reduced by desensitizing patient antibodies, according to research...
Scientists Show How Cells React to Injury From Open-Heart Surgery
News | Cardiovascular Surgery | May 04, 2017
Cedars-Sinai Heart Institute investigators have learned how cardiac muscle cells react to a certain type of injury that...
ERACS Session Highlights Need for Standardized Best Practices in Cardiac Surgery
News | Cardiovascular Surgery | May 02, 2017
The recently formed group Enhanced Recovery After Cardiac Surgery (ERACS) hosted an organizing session in Boston on...
ClearFlow Receives Frost & Sullivan New Product Innovation Award for PleuraFlow Technology
News | Cardiovascular Surgery | May 01, 2017
ClearFlow Inc. has received the prestigious 2017 Global Frost & Sullivan Award for New Product Innovation. The...
Overlay Init